Does OCRELIZUMAB Cause Sinus tachycardia? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Sinus tachycardia have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.0% of all adverse event reports for OCRELIZUMAB.
25
Reports of Sinus tachycardia with OCRELIZUMAB
0.0%
of all OCRELIZUMAB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Sinus tachycardia From OCRELIZUMAB?
Of the 25 reports, 1 (4.0%) resulted in death, 11 (44.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Sinus tachycardia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Sinus tachycardia?
CLOZAPINE (598)
QUETIAPINE (593)
BUPROPION (311)
OLANZAPINE (296)
ACETAMINOPHEN (267)
VENLAFAXINE (263)
CYCLOPHOSPHAMIDE (247)
RISPERIDONE (244)
ARIPIPRAZOLE (236)
AMLODIPINE (228)
Which OCRELIZUMAB Alternatives Have Lower Sinus tachycardia Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE